Contact NHS 111 for urgent non-emergency advice
1: Growing Demand for Weight-Loss Drugs The most direct consequence of the recent developments is the growth in demand for the weight-loss drugs themselves
Weight management medications include all obesity and anorexiants agents
M.DuY.LouJ.GurbuzS.et al (2023)
Martin CK, Carmichael OT, Carnell S, Considine RV, Kareken DA, Dydak U, et al
It's important to note that while Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for chronic weight management, Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes management, though they may be prescribed off-label for weight loss